1Settimana·

$OSCR vs $HIMS

$OSCR caught my attention from the start. I see $OSCR as a potential next $HIMS (+2,18%). After analyzing the stock in depth — including leadership and financial conditions — calling $OSCR undervalued is an understatement. Of course, it’s a highly risky and volatile position. Not for the faint of heart, especially when putting in large amounts of capital ;)

Aktienfox

@Aktienfox

1Settimana·

Hims vs. OSCAR Health

$OSCR vs $HIMS (+2,18%)

2 Commenti

Jonas@Leipziger_Jung

1Settimana

You have to keep an eye on ACA cuts next year. Oscar is heavily reliant on these but also making some steps in derversifying their income streams. Was my reason for not starting a position some months ago and for me the main reason why this stock is so "undervalued". Nontheless i have to admit, that to me the market seems to price in a kinda "worst case scenario" , which I hink won't happen

•

MirQ@TheYoungDipBuyer

1Settimana

@Leipziger_Jung Great observation, the regulatory perspective is a key focal point. That said, OSCR has a strong position from an economic standpoint, which could be a major advantage. Additionally, the CEO has purchased a significant number of shares and given some interesting interviews. We’ll see how things develop

•